Charlotte Kilstrup-Nielsen

Dr. Charlotte Kilstrup-Nielsen


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2005 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
Francesca MariFrancesca Mari
Francesca Mari
SASara Azimonti
Sara Azimonti
IBIlaria Bertani
Ilaria Bertani
FBFabrizio Bolognese
Fabrizio Bolognese
ECElena Colombo
Elena Colombo
NLNicoletta Landsberger
Nicoletta Landsberger
Rett syndrome (RTT) is a severe neurodevelopmental disorder almost exclusively affecting females and characterized by a wide spectrum of clinical manifestations. Most patients affected by classic RTT and a smaller percentage of patients with the milder form ‘preserved speech variant’ have either point mutations or deletions/duplications in the MECP2 gene. Recently, mutations in the CDKL5 gene, coding for a putative kinase, have been found in female patients with a phenotype overlapping with that of RTT. Here, we report two patients with the early seizure variant of RTT, bearing two novel CDKL5 truncating mutations, strengthening the correlation between CDKL5 and RTT. Considering the similar phenotypes caused by mutations in MECP2 and CDKL5, it has been suggested that the two genes play a role in common pathogenic processes. We show here that CDKL5 is a nuclear protein whose expression in the nervous system overlaps with that of MeCP2, during neural maturation and synaptogenesis. Importantly, we demonstrate that MeCP2 and CDKL5 interact both in vivo and in vitro and that CDKL5 is indeed a kinase, which is able to phosphorylate itself and to mediate MeCP2 phosphorylation, suggesting that they belong to the same molecular pathway. Furthermore, this paper contributes to the clarification of the phenotype associated with CDKL5 mutations and indicates that CDKL5 should be analyzed in each patient showing a clinical course similar to RTT but characterized by a lack of an early normal period due to the presence of seizures.

26 August 2012 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
SRSara Ricciardi
Sara Ricciardi
FUFederica Ungaro
Federica Ungaro
MHMelanie Hambrock
Melanie Hambrock
NRNils Rademacher
Nils Rademacher
GSGilda Stefanelli
Gilda Stefanelli
VBVania Broccoli
Vania Broccoli

1 October 2008 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LRLaura Rusconi
Laura Rusconi
LSLisa Salvatoni
Lisa Salvatoni
LGLaura Giudici
Laura Giudici
IBIlaria Bertani
Ilaria Bertani
CKCharlotte Kilstrup-Nielsen
Charlotte Kilstrup-Nielsen
NLNicoletta Landsberger
Nicoletta Landsberger
Mutations in the human X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identified in patients with Rett syndrome (RTT), West syndrome, and X-linked infantile spasms, sharing the common feature of mental retardation and early seizures. CDKL5 is a rather uncharacterized kinase, but its involvement in RTT seems to be explained by the fact that it works upstream of MeCP2, the main cause of Rett syndrome. To understand the role of this kinase for nervous system functions and to address if molecular mechanisms are involved in regulating its distribution and activity, we studied the ontogeny of CDKL5 expression in developing mouse brains by immunostaining and Western blotting. The expression profile of CDKL5 was compared with that of MeCP2. The two proteins share a general expression profile in the adult mouse brain, but CDKL5 levels appear to be highly modulated at the regional level. Its expression is strongly induced in early postnatal stages, and in the adult brain CDKL5 is present in mature neurons, but not in astroglia. Interestingly, the presence of CDKL5 in the cell nucleus varies at the regional level of the adult brain and is developmentally regulated. CDKL5 shuttles between the cytoplasm and the nucleus and the C-terminal tail is involved in localizing the protein to the cytoplasm in a mechanism depending on active nuclear export. Accordingly, Rett derivatives containing disease-causing truncations of the C terminus are constitutively nuclear, suggesting that they might act as gain of function mutations in this cellular compartment.

15 April 1999 in Genes & Development
Verified
Journal Article
Open access
PDF file
JBJens Berthelsen
Jens Berthelsen
CKCharlotte Kilstrup-Nielsen
Charlotte Kilstrup-Nielsen
FBFrancesco Blasi
Francesco Blasi
FMFulvio Mavilio
Fulvio Mavilio
VZVincenzo Zappavigna
Vincenzo Zappavigna
Nuclear localization of the Extradenticle (EXD) and PBX1 proteins is regionally restricted during Drosophila and mammalian development. We studied the subcellular localization of EXD, PBX, and their partners Homothorax (HTH) and PREP1, in different cell contexts. HTH and PREP1 are cytoplasmic and require association with EXD/PBX for nuclear localization. EXD and PBX1 are nuclear in murine fibroblasts but not in Drosophila Schneider cells, in which they are actively exported to the cytoplasm. Coexpression of EXD/PBX with HTH/PREP1 causes nuclear localization of their heterodimers in both cell contexts. We propose that heterodimerization with HTH/PREP induces nuclear translocation of EXD and PBX1 in specific cell contexts by blocking their nuclear export.

24 August 2006 in Journal of Biological Chemistry
Verified
Journal Article
Closed access
IBIlaria Bertani
Ilaria Bertani
LRLaura Rusconi
Laura Rusconi
FBFabrizio Bolognese
Fabrizio Bolognese
GFGreta Forlani
Greta Forlani
BCBarbara Conca
Barbara Conca
CKCharlotte Kilstrup-Nielsen
Charlotte Kilstrup-Nielsen

13 August 2014 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
EBElisa Bellini
Elisa Bellini
GPGiulio Pavesi
Giulio Pavesi
IBIsabella Barbiero
Isabella Barbiero
ABAnna Bergo
Anna Bergo
CCChetan Chandola
Chetan Chandola
NLNicoletta Landsberger
Nicoletta Landsberger
Although Rett syndrome (RTT) represents one of the most frequent forms of severe intellectual disability in females worldwide, we still have an inadequate knowledge of the many roles played by MeCP2 (whose mutations are responsible for most cases of RTT) and their relevance for RTT pathobiology. Several studies support a role of MeCP2 in the regulation of synaptic plasticity and homeostasis. At the molecular level, MeCP2 is described as a repressor capable of inhibiting gene transcription through chromatin compaction. Indeed, it interacts with several chromatin remodeling factors, such as HDAC-containing complexes and ATRX. Other studies have inferred that MeCP2 functions also as an activator; a role in regulating mRNA splicing and in modulating protein synthesis has also been proposed. Further, MeCP2 avidly binds both 5-methyl- and 5-hydroxymethyl-cytosine. Recent evidence suggests that it is the highly disorganized structure of MeCP2, together with its post-translational modifications (PTMs) that generate and regulate this functional versatility. Indeed, several reports have demonstrated that differential phosphorylation of MeCP2 is a key mechanism by which the methyl binding protein modulates its affinity for its partners, gene expression and cellular adaptations to stimuli and neuronal plasticity. As logic consequence, generation of phospho-defective Mecp2 knock-in mice has permitted associating alterations in neuronal morphology, circuit formation, and mouse behavioral phenotypes with specific phosphorylation events. MeCP2 undergoes various other PTMs, including acetylation, ubiquitination and sumoylation, whose functional roles remain largely unexplored. These results, together with the genome-wide distribution of MeCP2 and its capability to substitute histone H1, recall the complex regulation of histones and suggest the relevance of quickly gaining a deeper comprehension of MeCP2 PTMs, the respective writers and readers and the consequent functional outcomes.